Delivery Order SPE2DX22D0010-SPE2D825FHF92
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Vyvanse 40 mg capsules (100-count packages) valued at $1,185.78. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 12, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $6,108.12 delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Vyvanse 10 mg capsules (100-count units). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,377.46 by the Defense Logistics Agency on September 22, 2025, for the supply of Vyvanse 50 mg capsules (100 count). The award, which is not set-aside and employs firm fixed price terms, represents a single delivery order under a larger contract vehicle. This order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) with a ceiling value of $6,688.50. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 26, 2025. The delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 6, 2025, for Vyvanse 40 mg capsules (100-count units) valued at $4,250.18. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, valued at $6,880.66 for 100 capsules of Vyvanse 20 mg. This contract is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award is part of the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 17, 2025, for 100 capsules of Vyvanse 30 mg with a ceiling value of $5,090.67. This competitively awarded, non-set-aside order is funded by the Defense Logistics Agency (DLA) and will be performed at the contractor's Conshohocken facility. The award represents a single delivery order under a larger Indefinite Delivery Contract vehicle. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $1,783.60. This firm fixed price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Vyvanse 40 mg capsules (100 count) with a ceiling value of $4,741.94. This contract is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order...